Aura Biosciences, Inc. 4

Insufficient information was provided to identify who traded what on this Form 4.

The provided document appears to be only an Exhibit 24 (power of attorney) reference without the core Form 4 tables that list the actual insider transactions, such as the reporting person, security, dates, number of shares, prices, or post-transaction holdings. Because the key transactional details are missing, it is not possible to determine what, if any, insider trades occurred, their type (purchase, sale, or award), size, or the insider’s role and ownership after the transaction.

Filing Facts

CIK

1501796

Ticker

AURA

Form

4

Source Type

fda

Accession

0002148785-26-000009

Alert Tier

4